Researchers have identified a previously unrecognized intracellular function of complement factor H (CFH) that provides neuroprotection during central nervous system (CNS) inflammation, offering new mechanistic insights into how neurons survive in the presence of immune-mediated injury. The study, published in Nature, reveals that this complement regulator—typically associated with the extracellular regulation of the complement cascade—is expressed within neurons, where it serves to mitigate the accumulation of reactive oxygen species (ROS) and lipid peroxidation.
To investigate the heterogeneity of neuronal vulnerability to inflammatory injury, the research team focused on retinal ganglion cells (RGCs), a neuronal population in the eye that frequently undergoes degeneration in patients with MS. Using single-nucleus RNA-sequencing (snRNA-seq) on samples obtained from MS donors and healthy control individuals, the investigators mapped the transcriptional landscapes of diverse RGC populations. The data analysis, performed using the Seurat pipeline to cluster cell types and identify differentially expressed genes, revealed that CFH expression was strongly associated with a cellular profile of intrinsic resilience to degeneration. This differential vulnerability provided a platform for characterizing the genetic determinants of neuroprotection, leading to the selection of CFH as a candidate for further experimental validation.
The methodology employed for the snRNA-seq analysis involved the isolation of nuclei from macular tissue, followed by library generation and sequencing on the Illumina NovaSeq 6000 platform. The researchers utilized the CellBender algorithm to account for ambient RNA interference and ensured that non-RGC nuclei were excluded through rigorous filtering of marker gene expression. By aggregating pseudobulk counts for susceptible versus resilient clusters, the team defined specific gene regulation modules, such as module A, which comprised genes upregulated in resilient RGCs compared to those classified as vulnerable. These module-defining genes were then used in AUCell analysis to quantify resilience and vulnerability scores across individual donors, further corroborating the correlation between CFH expression and protective neuronal strategies.
Mechanistically, the investigators demonstrated that CFH is induced in both retinal and other CNS neurons in response to inflammatory stressors such as interferon-gamma (IFNγ) and elevated oxidative stress. This localization is biologically significant because the endoplasmic reticulum is increasingly recognized as a key site of lipid peroxidation in neurons. Experimental imaging using the BODIPY C11 probe, which shifts fluorescence in the presence of oxidized lipids, confirmed that neurons expressing intracellular CFH were protected against the accumulation of oxidized species. This protective effect was maintained even in the presence of strong stressors such as glutamate or the ferroptosis-inducer RSL3, provided that functional CFH was present within the cytoplasm or endoplasmic reticulum.
Detailed structural analysis revealed that the protective function of CFH is highly dependent on its C-terminal SCR20 domain. The study compared this with other regions of the protein, noting that the SCR7 region—which contains the age-related macular degeneration (AMD)-associated Y402H variant—was dispensable for neuroprotection against oxidative stress. Furthermore, experiments involving the conditional knockout of Cfh in neuronal cultures and in mice confirmed that the neuroprotective activity occurs independently of complement secretion and does not require the presence of complement component C3. By comparing neuronal survival in Cfh-deficient neurons and those expressing exogenous CFH constructs, the team demonstrated that protection is preserved when CFH is artificially retained in the endoplasmic reticulum or the cytoplasm, likely through the sequestration of proteins modified by malondialdehyde, a byproduct of lipid peroxidation.
The importance of this mechanism was validated in vivo using the EAE mouse model of MS, in which mice were immunized with the MOG35–55 peptide to induce inflammatory demyelination and neurodegeneration. Researchers monitored clinical deficits using a standard scoring system ranging from 0 (no clinical signs) to 5 (premorbid state or death). To evaluate visual function, the team employed the OptoDrum system, which measures the optomotor reflex through head-tracking movements in response to rotating visual gratings. These experiments demonstrated that mice treated with CFH-expressing effector constructs exhibited improved visual acuity and contrast sensitivity, and showed reduced motor deficits compared to littermates receiving control AAVs. The study positioned these findings as a broadly conserved strategy, noting that while CFH is constitutively expressed in RGCs to counter light-induced oxidative stress, other CNS neurons like cortical and spinal motor neurons activate this defense only under pathological inflammatory conditions.
To gain further insight into the interactome of intracellular CFH, the researchers utilized proximity-dependent biotinylation with TurboID. By targeting TurboID to the endoplasmic reticulum or the cytoplasm and pulsing cells with biotin, the team was able to capture and identify interacting proteins via LC-MS/MS-based proteomics. The resulting data suggested that intracellular CFH acts as a critical regulator of the protective stress response, potentially functioning as a counterbalance to the degradation of the enzyme GPX4, which is often driven by the STING signaling pathway during inflammation. This interaction suggests that intracellular CFH helps maintain the integrity of the cellular lipid environment by preventing the self-perpetuating cycle of ROS accumulation, lipid peroxidation, and subsequent cell death.
They observe that the intracellular function of CFH may reflect distinct splice variants or conformational states that differ from its known extracellular form. Nonetheless, the consistency of results across in vitro neuronal cultures, mouse models of EAE, and human snRNA-seq datasets supports the conclusion that enhancing intracellular CFH expression represents a promising therapeutic target for mitigating inflammation-induced neurodegeneration.
The study also addressed the role of different neuronal pathways in the susceptibility to MS. Consistent with clinical evidence of early dyschromatopsia and optic neuritis, the researchers found that midget RGCs, which belong to the parvocellular color-vision pathway, were among the most vulnerable populations in MS. Melanopsin-expressing ipRGCs also demonstrated susceptibility, mirroring clinical reports of their early loss in neurodegenerative diseases including Alzheimer’s. By comparing the transcriptional profiles of these highly vulnerable cells against more resilient types, such as PG-ON RGCs, the team effectively mapped the transcriptional landscape of neuronal resilience.
By identifying CFH as a mediator of resilience against ferroptosis, this study provides a new framework for understanding neuronal survival strategies.
Subject of Research: Identification of a non-canonical intracellular role for complement factor H in neuronal resilience against inflammatory stress.
Article Title: Intracellular complement factor H protects neurons during CNS inflammation
Article References: Mayer, C., Woo, M. S., Sonner, J. K., Binkle-Ladisch, L., Fischbach, F., Sekol, P., Smith, M. D., Lucas-Ruiz, F., Manteufel, D., Mattern, K. M. J., Pfeffer, L. K., Guo, Y., Siebels, B., Miguela, A., Vieira, V., Meurs, N., Bauer, S., Schwarz, S., Wulf, S., … Friese, M. A. (2026). Intracellular complement factor H protects neurons during CNS inflammation. Nature, 658(8136), 765-773. https://doi.org/10.1038/s41586-026-10981-y
Image Credits: AI Generated
DOI: 10.1038/s41586-026-10981-y
Keywords: neuroprotection, complement factor H, multiple sclerosis, neurodegeneration, retinal ganglion cells, lipid peroxidation, ferroptosis, endoplasmic reticulum, oxidative stress, experimental autoimmune encephalomyelitis, snRNA-seq, neuronal resilience, CFH, neuroinflammation, TurboID
Cite Scienmag News
Diana Fleming. (November 17, 2026). Intracellular Complement Factor H Protects Neurons During CNS Inflammation. Scienmag. https://scienmag.com/intracellular-complement-factor-h-protects-neurons-during-cns-inflammation/
Diana Fleming. "Intracellular Complement Factor H Protects Neurons During CNS Inflammation." Scienmag, 17 November 2026, https://scienmag.com/intracellular-complement-factor-h-protects-neurons-during-cns-inflammation/. Accessed 17 November 2026.
Diana Fleming. "Intracellular Complement Factor H Protects Neurons During CNS Inflammation." Scienmag. November 17, 2026. https://scienmag.com/intracellular-complement-factor-h-protects-neurons-during-cns-inflammation/








